Ameet Nath­wani re­bounds from Sanofi purge to helm Dew­point; Ali Mor­taza­vi named CEO at e-ther­a­peu­tics

→ Sanofi vet Ameet Nath­wani has joined Arie Bellde­grun and ARCH Ven­ture Part­ners-backed Dew­point Ther­a­peu­tics as its new CEO. Dur­ing his tenure at Sanofi, Nath­wani served as CMO, chief dig­i­tal of­fi­cer and ex­ec­u­tive com­mit­tee mem­ber. Pri­or to that, Nath­wani com­plet­ed a 12-year stint at No­var­tis, where he held roles such as glob­al head of the crit­i­cal care busi­ness fran­chise and SVP and glob­al de­vel­op­ment head of the car­dio­vas­cu­lar and me­tab­o­lism fran­chise.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER